Table 1

General indicators

QI 1 - Number of newly diagnosed cases of endometrial carcinoma treated per center per year
TypeStructural indicator
DescriptionNumber of newly diagnosed cases of endometrial carcinoma treated (surgically or not surgically) per center per year.
Specifications Numerator: number of newly diagnosed endometrial carcinoma cases treated per center per year.
Denominator: not applicable.
TargetsOptimal target: ≥90
Minimum required target: ≥50
QI 2 - Number of endometrial carcinoma primary surgeries (including early and advanced stages) performed per center per year
TypeStructural indicator
DescriptionPrimary surgeries, including lymph node assessment, hysterectomy, and cytoreductive surgeries for early and advanced-stage endometrial carcinoma
Specifications Numerator: number of patients undergoing a primary surgery as defined above performed per center per year
Denominator: not applicable
TargetsOptimal target: ≥80
Minimum required target: ≥50
QI 3 - Surgery performed by a gynecologic oncologist or a trained surgeon specifically dedicated to gynecological cancer management
TypeProcess indicator
DescriptionSurgery is performed or supervised by a certified gynecologic oncologist, or in countries where certification is not established, by a trained surgeon dedicated to the management of gynecological cancer (accounting for more than 80% of his or her practice) or having completed an ESGO-certified fellowship
Specifications Numerator: number of patients with endometrial carcinoma operated by a surgical specialist as defined above or supervised by this category
Denominator: number of patients with endometrial carcinoma undergoing surgery
Target≥95%
QI 4 - Treatment and/or follow-up plan discussed at a multi-disciplinary team meeting
TypeProcess indicator
DescriptionThe decision for any therapeutic intervention and/or follow-up plan has been made by a multi-disciplinary team including at least a certified gynecologic oncologist (or in countries where certification is not organized, a trained surgeon dedicated to the management of gynecological cancer (accounting for more than 80% of his or her practice) or having completed an ESGO-certified fellowship), a radiologist, a radiation oncologist, a physician certified to deliver chemotherapy (a gynecologic oncologist and/or a physician with special interest to gynecologic oncology (medical or clinical oncologist)), and a pathologist
Specifications Primary treatment:
  • Numerator: number of patients with endometrial carcinoma in whom the decision for any primary treatment has been made by a multi-disciplinary team

  • Denominator: all patients presenting with newly diagnosed endometrial carcinoma


Relapse treatment:
  • Numerator: number of patients with endometrial carcinoma in whom the decision for any relapse treatment has been made by a multi-disciplinary team

  • Denominator: all patients presenting with relapsed endometrial carcinoma

TargetsPrimary treatment: 90%
Relapse treatment: 99%
QI 5 - Center participating in ongoing prospective studies in gynecological oncology
TypeStructural indicator
DescriptionThe center actively accrues patients in ongoing prospective studies (including notably studies on imaging, translational research, quality of life, and/or tissue procurement) in gynecological oncology. The studies should be approved by an ethical committee
Specifications Numerator: not applicable
Denominator: not applicable
TargetsOptimal target: participation in ongoing prospective studies in endometrial carcinoma
Minimum required target: participation in ongoing prospective studies in gynecological oncology